In addition to elevations in IAP proteins, we previously identified direct inhibition of caspase-2 translation by the ubiquitous mRNA-binding protein human antigen R (HuR) as a novel path of therapy resistance in colon carcinoma cells [6,7,8] (for a review, see [9]). The gene discussed is ELAVL1; the disease is colon carcinoma.